Pembrolizumab for advanced melanoma not previously treated with ipilimumab

Technology appraisal guidance
Reference number: TA366
Published: 25 November 2015
Last updated: 12 September 2017

History

Invitation to participate

Equality Impact Assessment (Guidance development) (PDF 155 KB)

Published:

26 November 2015

Final appraisal determination

Final appraisal determination
Appraisal consultation document Final appraisal determination document (PDF 384 KB)

Published:

09 October 2015
Committee papers (PDF 8.28 MB)

Published:

09 October 2015

Final scope

Final scope (PDF 99 KB)

Published:

08 May 2015

Final matrix

Final matrix (PDF 101 KB)

Published:

08 May 2015

NICE response to comments on the draft scope and provisional matrix

NICE response to comments on the draft scope and provisional matrix (PDF 228 KB)

Published:

08 May 2015

Equality impact assessment - scoping

Equality impact assessment - scoping (PDF 121 KB)

Published:

08 May 2015

Draft scope for consultation (pre-referral) - July 2014

Draft scope for consultation (pre-referral) - July 2014 (PDF 110 KB)

Published:

09 April 2015

Provisional matrix (pre-referral) - July 2014

Provisional matrix (pre-referral) - July 2014 (PDF 103 KB)

Published:

09 April 2015